Bristol-Myers Squibb Reports First Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro boost AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
Bristol-Myers Squibb Co. (BMY) PT Raised to $53 at Deutsche Bank
April 27, 2018 9:19 AM EDTDeutsche Bank raised its price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $53.00 (from $52.00) while maintaining a Hold rating.
... MoreBristol-Myers Squibb (BMY) Tops Q1 EPS by 9c; Raises Outlook
April 26, 2018 7:01 AM EDTBristol-Myers Squibb (NYSE: BMY) reported Q1 EPS of $0.94, $0.09 better than the analyst estimate of $0.85. Revenue for the quarter came in at $5.2 billion versus the consensus estimate of $5.24 billion.
GUIDANCE:
Bristol-Myers Squibb sees FY2018 EPS of $3.35-$3.45, versus the consensus of... More


